Long-Term Performance and Safety of the Self-Expandable Carotid Stent MER: 5-Year Outcomes from the OCEANUS Study, with Subgroup Analysis Based on Predilatation Before Carotid Artery Stenting
Authors:
- Przemysław NowakowskiPNPrzemysław Nowakowski
- Mariola SznapkaMSMariola Sznapka
- Adam KobayashiAKAdam Kobayashi
- Jacek BilJBJacek Bil
- Piotr PaluszekPPPiotr Paluszek
- Eugeniusz HrycekEHEugeniusz Hrycek
- Zofia NowakowskaZNZofia Nowakowska
- Michał NowakowskiMNMichał Nowakowski
- Aleksandra SuchanekASAleksandra Suchanek
- Piotr PieniążekPPPiotr Pieniążek
Open Access
- 18 April 2025
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (8) , 2814
Abstract
Background: Carotid artery stenting (CAS) with neuroprotection is a widely used treatment for carotid artery stenosis. This study aimed to evaluate the long-term outcomes of CAS using the MER stent (Balton, Poland) and various neuroprotection devices, with subgroup analysis based on predilatation. Methods: A prospective analysis was conducted on patients treated with CAS at four high-volume centers in Poland between October 2016 and May 2017. Patients were stratified into two groups based on whether predilatation was performed. Procedural and clinical outcomes, including major adverse events (MAEs) defined as all-cause death, stroke, and myocardial infarction (MI), were evaluated at 30 days and 5 years post-procedure. Kaplan–Meier analysis and Cox regression models were used to assess event-free survival and predictors of MAEs. Results: The study population consisted of 100 patients (males: 61%) with a mean age of 68 years. Dyslipidemia (84.4% vs. 60.0%, p = 0.007) and smoking (67.3% vs. 44.4%, p = 0.022) differed significantly between the predilatation and non-predilatation groups. The procedural success rate (p = 0.03). Conclusions: CAS with the MER stent demonstrated high procedural success and favorable long-term outcomes. Predilatation did not impact outcomes. Neuroprotection was effective in all cases, with no device-related complications reported.Keywords
Funding Information
- Balton (Warsaw, Poland)
This publication has 27 references indexed in Scilit:
- Carotid artery stenting versus carotid endarterectomy for symptomatic or asymptomatic extracranial carotid stenosis: A national cohort studyJournal of Stroke and Cerebrovascular Diseases, 2024
- New Ischemic Cerebral Lesions in Postprocedural Magnetic Resonance Imaging in Carotid Artery Stenting Versus Carotid Endarterectomy: A Systematic Review and Meta-AnalysisAnnals of Vascular Surgery, 2024
- Long-term outcomes of carotid stenting in a single neurovascular center: up to 12-year retrospective analysis with a focus on the influence of comorbiditiesNeuroradiology, 2023
- Carotid Artery Stenting versus Carotid Endarterectomy in Terms of Neuroprotection DW-MRI Detected and Neuropsychological Assessment ImpairmentAnnals of Vascular Surgery, 2023
- Editor's Choice – European Society for Vascular Surgery (ESVS) 2023 Clinical Practice Guidelines on the Management of Atherosclerotic Carotid and Vertebral Artery DiseaseEuropean Journal of Vascular and Endovascular Surgery, 2022
- Society for Vascular Surgery clinical practice guidelines for management of extracranial cerebrovascular diseaseJournal of Vascular Surgery, 2022
- OCEANUS (PrOspective multiCentEr Study of cArotid Artery steNting Using mer Stent) Study: 30 Day and Two Year ResultsEuropean Journal of Vascular and Endovascular Surgery, 2021
- Hemodynamic events during carotid stenting are associated with significant periprocedural stroke and adverse eventsJournal of Vascular Surgery, 2020
- Proximal embolic protection versus distal filter protection versus combined protection in carotid artery stenting: A systematic review and meta-analysisCardiovascular Revascularization Medicine, 2018
- Progression of asymptomatic carotid stenosis despite optimal medical therapyJournal of Vascular Surgery, 2013